3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Central Nervous System Neoplasms
1
Interventions
Pemetrexed
4
Spinal Puncture
3
Radiotherapy
3
aflutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pertuzumab
1
lorlatinib
1
azeliragon
1
adavosertib
1
Trastuzumab
1
Referral and Consultation
1
Radiation
1
Physical Examination
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
GDC-0084
1
Drug Therapy
1
Deferoxamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
tipifarnib
×
90 days
×
Clear all
No trials found.